Craneware PLC
LSE:CRW
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 590
2 470
|
Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one CRW stock under the Base Case scenario is 2 004.47 GBX. Compared to the current market price of 2 320 GBX, Craneware PLC is Overvalued by 14%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Craneware PLC
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for CRW cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Craneware PLC
Balance Sheet Decomposition
Craneware PLC
Current Assets | 93.2m |
Cash & Short-Term Investments | 34.6m |
Receivables | 58.6m |
Non-Current Assets | 450.4m |
PP&E | 8.6m |
Intangibles | 437.5m |
Other Non-Current Assets | 4.4m |
Current Liabilities | 148.8m |
Accounts Payable | 17.2m |
Other Current Liabilities | 131.5m |
Non-Current Liabilities | 66.3m |
Long-Term Debt | 31.2m |
Other Non-Current Liabilities | 35.1m |
Earnings Waterfall
Craneware PLC
Revenue
|
189.3m
USD
|
Cost of Revenue
|
-27.1m
USD
|
Gross Profit
|
162.2m
USD
|
Operating Expenses
|
-140.7m
USD
|
Operating Income
|
21.5m
USD
|
Other Expenses
|
-9.8m
USD
|
Net Income
|
11.7m
USD
|
Free Cash Flow Analysis
Craneware PLC
USD | |
Free Cash Flow | USD |
The company reported a robust year with a 9% increase in revenue, reaching $189.3 million, and a 6% growth in EBITDA to $58.3 million. EPS also rose by 9%. With careful cost management, the company maintained a 31% EBITDA margin. Highlighting its strong cash flow, 90% of EBITDA converted to operating cash. Despite a high-interest environment, the company reduced debt by 58%, leaving $35.4 million outstanding. Robust deferred income growth of over 30% signals strong future sales, while continued investment in R&D, with 30% of revenue capitalized, underscores the focus on innovation and long-term growth.
What is Earnings Call?
CRW Profitability Score
Profitability Due Diligence
Craneware PLC's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
Craneware PLC's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
CRW Solvency Score
Solvency Due Diligence
Craneware PLC's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Score
Craneware PLC's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CRW Price Targets Summary
Craneware PLC
According to Wall Street analysts, the average 1-year price target for CRW is 2 886.86 GBX with a low forecast of 2 727 GBX and a high forecast of 3 150 GBX.
Dividends
Current shareholder yield for CRW is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Craneware Plc engages in the provision of software and support services for the healthcare industry. The firm's Value Cycle Solutions has five product families, which include Patient Engagement, Charge Capture & Pricing, Claims Analytics, Cost and Margin Analytics, and Revenue Recovery & Retention. Its Patient Engagement solutions include InSight Medical Necessity, which provides access to medical necessity and prior authorization policies for Medicare, Medicare supplements and commercial payors impacting customers facility. Its Charge Capture & Pricing solution include Chargemaster Toolkit, Trisus Pricing Transparency, Trisus Pharmacy Financial Management, Trisus Pricing Analyzer, Online Reference Toolkit, and others. Its Claims Analytics solution include Trisus Claims Informatics. Its Revenue Recovery & Retention solution include InSight Denials, InSight Audit and Appeals Services.
Officers
The intrinsic value of one CRW stock under the Base Case scenario is 2 004.47 GBX.
Compared to the current market price of 2 320 GBX, Craneware PLC is Overvalued by 14%.